What are the effects and functions of IV prochlorpera?

Intravenous immunoglobulin is an injectable drug. It is a transparent liquid and odorless. Injection of intravenous immunoglobulin can have health benefits for the human body, enhance human resistance, and regulate the body. It is very good for the body and can be injected into the body. Injection of intravenous immunoglobulin can also supplement the body's globulin, have antibacterial effects, and have a conditioning function for the human body.

Effects of IV

Former name : Lyophilized low pH human immunoglobulin for intravenous injection.

Category : Blood products.

Specifications : Based on immunoglobulin G (1) 1g (2) 1.25g (3) 2.5g (4) 5g

Storage and shelf life : Store in a dark place at 2-8℃. Valid for 5 years.

Main components: More than 95% of the protein in this product is immunoglobulin. [Properties] White loose body, no signs of melting. After reconstitution, it becomes a colorless or light yellow clear liquid with slight opalescence. [Edit this section] Pharmacological action: This product contains broad-spectrum IgG antibodies against viruses, bacteria or other pathogens. In addition, the unique type of immunoglobulin and the unique antibody can form a complex immune network, so it has the dual therapeutic effects of immune replacement and immune regulation. After intravenous injection, it can rapidly increase the IgG level in the recipient's blood, enhancing the body's anti-infection ability and immune regulation function.

Indications

This product contains IgG antibodies against a wide spectrum of viruses and bacteria, has a conditioning and neutralizing effect, and can rapidly increase the IgG level in the recipient's blood after intravenous infusion.

(1) Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc.

(2) Secondary immunoglobulin deficiency diseases, such as severe infections, neonatal sepsis, etc.

(3) Autoimmune diseases, such as idiopathic thrombocytopenic purpura.

Indications

Primary or secondary immunoglobulin IgG deficiency or hypofunction; idiopathic thrombocytopenic purpura; severe infections caused by various bacteria and viruses; Kawasaki disease: Other indications: It can be used for other immune regulation disorders and corrections, such as rheumatoid arthritis, myasthenia gravis, autoimmune anemia and immune-mediated simple red cell aplasia, and can also be used for hemophilia that produces anti-coagulation factor VIII antibodies.

Specification

The content of 1gG is 50g/1, and the packaging volume of 1gG is 1g/20ml/bottle, 1.25g/25ml/bottle, 2.5g/50ml/bottle, 5g/100ml/10g/200ml/bottle.

Quality Advantage

This product is produced in full compliance with GMP, with reliable quality and good stability. It is separated and extracted using the internationally advanced low-temperature ethanol filter press process, and the product has high purity. It uses a double virus inactivation process of 60℃ 10 hours pasteurization and low pH incubation to ensure product safety.

Precautions

This product should be infused once (the unused portion should be discarded) and should not be divided into multiple times or infused by a second person. If the solution appears turbid, frozen, contains foreign matter, floccules, or has precipitates that cannot be shaken off, it should not be used; this product should be strictly infused alone. It should not be mixed with other drugs or solutions. If necessary, it can be diluted with 5% glucose solution. Patients with diabetes or severe acid-base metabolism disorders should use it with caution. This product is for intravenous infusion only. If any adverse reaction is found during the infusion, the infusion should be stopped immediately and appropriate treatment should be given. [Edit this paragraph] Preparation method: Fresh plasma is taken from healthy blood donors, and each batch should be mixed with plasma from at least 1,000 healthy blood donors. The immunoglobulin components are extracted by segmented precipitation using the low-temperature ethanol protein separation method, and are obtained through ultrafiltration or freeze-drying, dealcoholization, concentration and virus inactivation. The purity of the immunoglobulin should not be less than 98%. The solution is prepared into a concentration of not less than 5% of immunoglobulin G, and an appropriate amount of stabilizer may be added, sterilized and filtered, and aseptically filled.

Characteristics

This product should be a colorless or light yellow clear liquid with a slight opalescence and should not contain foreign matter, floccules or precipitation.